ARWRArrowhead Pharmaceuticals, Inc.
$60.78+90% 1Y
$60.78
$31.6652 weeks$89.61
Is the price fair?
What ARWR's price assumes
Arrowhead Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 16.7× revenue.
16.7
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 24.0
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 14.3
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 24.0
- EV / EBIToperating margin −34%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 14.3
- Market capitalisation
- $11.2B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.